Where is Verogen located?

Verogen is headquartered in San Diego, United States. It is registered at San Diego, California.

How many employees does Verogen have?

As of May 31, 2026, the latest employee count at Verogen is 17.

Where does Verogen rank among its competitors?

Verogen ranks 110th amongst 556 active competitors, of which 79 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Nanopore Technologies, which secured $102M in Aug, 2024.

Who are the top competitors of Verogen?

Verogen's top competitors include Nanopore Technologies, Siemens Healthineers and PacBio. Among them, Nanopore Technologies secured the most recent funding round in August, 2024.

Verogen - 2026 Company Profile, Funding & Competitors

Q: Is Verogen an acquired company?

Verogen got acquired by Qiagen on Jan 09, 2023.

Verogen is an acquired company based in San Diego (United States), founded in 2017. It operates as a Provider of DNA sequencing platform for forensic science. The company has 556 active competitors, including 79 funded and 85 that have exited. Its top competitors include companies like Nanopore Technologies, Siemens Healthineers and PacBio.

Company Details

Verogen is developing a DNA sequencing platform for forensic science. Its flagship product, MiSeq FGx Forensic Genomics System analyzes forensically relevant markers (STRs and SNPs) in a single interrogation. It has got FBI Approval for use by forensic laboratories generating DNA profiles for upload to the National DNA Index System (NDIS).

Website: verogen.com
Social
Email ID: *****@verogen.com
Phone Number: +1 **********
Registered Address: San Diego, California

Key Metrics

Founded Year

2017

Location

San Diego, United States

Stage

Acquired

Investors

1315 Capital & 1 more

Ranked

110^th among 556 active competitors

Employee Count

17 as on May 31, 2026

Investment & Acquisitions

GEDmatch

Similar Companies

Nanopore Technologies & 588 more

Exit Details

Acquired by Qiagen (Jan 09, 2023)

View Verogen's full profile

Verogen is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
VEROGEN, INC. CIN: 821673256 , United States, Active	Dec 26, 999	-	47 (As on Dec 31, 2022)	-

Verogen got acquired by Qiagen on Jan 09, 2023 at an acquisition amount of $*****.

Click here to take a look at Verogen's acquisition in detail

Verogen is a funded company. Verogen has 2 institutional investors.

View details of Verogen's funding rounds and investors

Verogen's employee count trend

Verogen has 17 employees as of May 26. Here is Verogen's employee count trend over the years:

Uncover Verogen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Verogen include Nanopore Technologies, Siemens Healthineers and PacBio. Here is the list of Top 10 competitors of Verogen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nanopore Technologies 2005, Oxford (United Kingdom), Public	Manufacturer of portable and benchtop devices for real-time DNA sequencing	$1.34B	IP Group, GIC & 94 others	75/100
2nd	Siemens Healthineers 2017, Forchheim (Germany), Public	Provider of medical imaging laboratory diagnostics and clinical digital solutions	-	Qatar Investment Authority, Skyviews Life Science ... & 3 others	75/100
3rd	PacBio 2004, Menlo Park (United States), Public	Developer of instrument systems and software for real-time sequencing of single-molecules	$410M	Deerfield, Kleiner Perkins & 24 others	72/100
4th	Illumina 1993, San Diego (United States), Public	Developer of technologies for analysis of genetic variation and function	$28M	Chevron Technology Ventures, Dow Chemical Company ... & 32 others	71/100
5th	Quanterix 2007, Cambridge (United States), Public	Developer of assay kits for ultra-sensitive biomarker detection	$99.5M	T. Rowe Price, Novalis LifeSciences & 15 others	71/100
6th	BioLife Solutions 1987, Bothell (United States), Acquired	Developer of cell and gene therapies with the integrity of a single cell	-	-	67/100
7th	Complete Genomics 2006, San Jose (United States), Acquired	Developer of DNA sequencing platform for human genome sequencing and analysis	$125M	Enterprise Partners Venture Capital, Orbimed ... & 8 others	66/100
8th	Biocare Medical 1997, Concord (United States), Acquired	Manufacturer of primary antibodies and instruments for immunohistochemistry applications	$85M	Excellere Partners, GHO Capital Partners & 3 others	65/100
9th	MGI 2016, Shenzhen (China), Series B	Provider of gene sequencing instruments, reagents, equipment, and related products	$1B	Guotai Junan Securities, CoStone Capital ... & 13 others	63/100
10th	Ultima Genomics 2016, Newark (United States), Series D	Developer of high-throughput NGS instrument for research	$600M	General Atlantic, Lightspeed Venture Partners ... & 8 others	62/100
110th	Verogen 2017, San Diego (United States), Acquired	Provider of DNA sequencing platform for forensic science	-	1315 Capital, Telegraph Hill Partners	36/100